SANDOZ FINASTERIDE A TABLET
Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
Tabia za bidhaa
(SPC)
04-12-2019
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
FINASTERIDE
Inapatikana kutoka:
SANDOZ CANADA INCORPORATED
ATC kanuni:
D11AX10
INN (Jina la Kimataifa):
FINASTERIDE
Kipimo:
1MG
Dawa fomu:
TABLET
Tungo:
FINASTERIDE 1MG
Njia ya uendeshaji:
ORAL
Vitengo katika mfuko:
30/100
Dawa ya aina:
Prescription
Eneo la matibabu:
MISC. SKIN AND MUCOUS MEMBRANE AGENTS
Bidhaa muhtasari:
Active ingredient group (AIG) number: 0124110002; AHFS:
Idhini hali ya:
APPROVED
Idhini ya tarehe:
2010-05-12
Tabia za bidhaa
_ _
_Sandoz Finasteride A _
_Page 1 of 22_
PRODUCT MONOGRAPH
PR SANDOZ FINASTERIDE A
Finasteride Tablets, USP
1 mg finasteride
Film-Coated Tablets
Type II 5α-reductase inhibitor
Sandoz Canada Inc.
110 Rue de Lauzon
Boucherville, QC
J4B 1E6
Date of Revision:
December 4, 2019
Submission Control No: 233397
_ _
_Sandoz Finasteride A _
_Page 2 of 22_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.......................................................... 3
SUMMARY
PRODUCT
INFORMATION
.................................................................................
3
INDICATIONS
AND
CLINICAL
USE
.......................................................................................
3
CONTRAINDICATIONS
............................................................................................................
3
WARNINGS
AND
PRECAUTIONS
..........................................................................................
3
ADVERSE
REACTIONS
............................................................................................................
5
DRUG
INTERACTIONS
.............................................................................................................
6
DOSAGE
AND
ADMINISTRATION
.........................................................................................
7
OVERDOSAGE
...........................................................................................................................
7
ACTION
AND
CLINICAL
PHARMACOLOGY
.......................................................................
8
STORAGE
AND
STABILITY.....................................................................................................
9
SPECIAL
HANDLING
INSTRUCTIONS
..................................................................................
9
DOSAGE
FORMS,
COMPOSITION
AND
PACKAGING ........................................................ 9
PART II: SCIENTIFIC INFORMATION
................................................................................
10
PHARMACEUTICAL
INFORMATION
Soma hati kamili
